228 related articles for article (PubMed ID: 17061122)
41. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
[TBL] [Abstract][Full Text] [Related]
42. The novel WT1 gene mutation p.H377N associated to Denys-Drash syndrome.
Guaragna MS; Soardi FC; Assumpção JG; Zambaldi Lde J; Cardinalli IA; Yunes JA; de Mello MP; Brandalise SR; Aguiar Sdos S
J Pediatr Hematol Oncol; 2010 Aug; 32(6):486-8. PubMed ID: 20562648
[TBL] [Abstract][Full Text] [Related]
43. Wilms' tumour 1 gene mutations in south Indian children with steroid-resistant nephrotic syndrome.
Kumar AS; Srilakshmi R; Karthickeyan S; Balakrishnan K; Padmaraj R; Senguttuvan P
Indian J Med Res; 2016 Aug; 144(2):276-280. PubMed ID: 27934809
[TBL] [Abstract][Full Text] [Related]
44. Clinical pictures and novel mutations of WT1-associated Denys-Drash syndrome in two Chinese children.
Yue Z; Pei Y; Sun L; Huang W; Huang H; Hu B; Yang J; Jiang X; Mo Y; Chen S; Lai KN; Wang Y
Ren Fail; 2011; 33(9):910-4. PubMed ID: 21851196
[TBL] [Abstract][Full Text] [Related]
45. WT1 microdeletion and slowly progressing focal glomerulosclerosis in a patient with male pseudohermaphroditism, childhood leukemia, Wilms tumor and cerebellar angioblastoma.
Buglyó G; Méhes G; Vargha G; Biró S; Mátyus J
Clin Nephrol; 2013 May; 79(5):414-8. PubMed ID: 23618379
[TBL] [Abstract][Full Text] [Related]
46. Focal Segmental Membranoproliferative Glomerulonephritis: A Histological Variant of Denys-Drash Syndrome.
Karmila AB; Yap YC; Appadurai M; Oh L; Fazarina M; Abd Ghani F; Ariffin H
Fetal Pediatr Pathol; 2021 Apr; 40(2):113-120. PubMed ID: 31707902
[No Abstract] [Full Text] [Related]
47. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes.
Morrison AA; Viney RL; Saleem MA; Ladomery MR
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F12-7. PubMed ID: 18385267
[TBL] [Abstract][Full Text] [Related]
48. Denys-Drash syndrome with neonatal renal failure in monozygotic twins due to c.1097G>A mutation in the WT1 gene.
Furtado LV; Pysher T; Opitz J; Lamb R; Comstock J; Batish S; Mauch T; Nelson R; Zhou H
Fetal Pediatr Pathol; 2011; 30(4):266-72. PubMed ID: 21434831
[TBL] [Abstract][Full Text] [Related]
49. A girl with bilateral ovarian tumours: Frasier syndrome.
Shimoyama H; Nakajima M; Naka H; Park YD; Hori K; Morikawa H; Yoshioka A
Eur J Pediatr; 2002 Feb; 161(2):81-3. PubMed ID: 11954756
[TBL] [Abstract][Full Text] [Related]
50. Hydrothorax in a patient with Denys-Drash syndrome associated with a diaphragmatic defect.
Cho HY; Lee BS; Kang CH; Kim WH; Ha IS; Cheong HI; Choi Y
Pediatr Nephrol; 2006 Dec; 21(12):1909-12. PubMed ID: 16932893
[TBL] [Abstract][Full Text] [Related]
51. Bilateral gonadoblastoma with dysgerminoma and pilocytic astrocytoma with WT1 GT-IVS9 mutation: A 46 XY phenotypic female with Frasier syndrome.
Subbiah V; Huff V; Wolff JE; Ketonen L; Lang FF; Stewart J; Langford L; Herzog CE
Pediatr Blood Cancer; 2009 Dec; 53(7):1349-51. PubMed ID: 19653292
[TBL] [Abstract][Full Text] [Related]
52. Frasier syndrome, part of the Denys Drash continuum or simply a WT1 gene associated disorder of intersex and nephropathy?
Koziell A; Charmandari E; Hindmarsh PC; Rees L; Scambler P; Brook CG
Clin Endocrinol (Oxf); 2000 Apr; 52(4):519-24. PubMed ID: 10762296
[TBL] [Abstract][Full Text] [Related]
53. WT1 exon 10 missense variant in a pediatric patient with focal segmental glomerulosclerosis with embryonal hyperplasia.
Kurokawa M; Nishimura M; Nishiyama K; Matsuoka K; Nagano C; Kaku Y
Pediatr Nephrol; 2024 Jul; 39(7):2083-2085. PubMed ID: 38265486
[TBL] [Abstract][Full Text] [Related]
54. A novel WT1 gene mutation in a newborn infant diagnosed with Denys-Drash syndrome.
Hakan N; Aydin M; Erdogan O; Cavusoglu YH; Aycan Z; Ozaltin F; Zenciroglu A; Apaydin S; Gunes R; Sahin G; Cinar G; Okumus N
Genet Couns; 2012; 23(2):255-61. PubMed ID: 22876585
[TBL] [Abstract][Full Text] [Related]
55. [Denys-Drash syndrome. Experience gathered in Erlangen illustrated by two case reports].
Zugor V; Zenker M; Dötsch J; Schrott KM; Schott GE
Urologe A; 2005 Oct; 44(10):1197-200. PubMed ID: 16003530
[TBL] [Abstract][Full Text] [Related]
56. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
[TBL] [Abstract][Full Text] [Related]
57. Denys-Drash syndrome associated WT1 glutamine 369 mutants have altered sequence-preferences and altered responses to epigenetic modifications.
Hashimoto H; Zhang X; Zheng Y; Wilson GG; Cheng X
Nucleic Acids Res; 2016 Dec; 44(21):10165-10176. PubMed ID: 27596598
[TBL] [Abstract][Full Text] [Related]
58. A novel WT1 gene mutation in a chinese girl with denys-drash syndrome.
Wang F; Cai J; Wang J; He M; Mao J; Zhu K; Zhao M; Guan Z; Li L; Jin H; Shu Q
J Clin Lab Anal; 2021 May; 35(5):e23769. PubMed ID: 33942367
[TBL] [Abstract][Full Text] [Related]
59. Focal segmental glomerulosclerosis in patients with complete deletion of one WT1 allele.
Iijima K; Someya T; Ito S; Nozu K; Nakanishi K; Matsuoka K; Ohashi H; Nagata M; Kamei K; Sasaki S
Pediatrics; 2012 Jun; 129(6):e1621-5. PubMed ID: 22585769
[TBL] [Abstract][Full Text] [Related]
60. WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis.
Yang Y; Jeanpierre C; Dressler GR; Lacoste M; Niaudet P; Gubler MC
Am J Pathol; 1999 Jan; 154(1):181-92. PubMed ID: 9916932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
